| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 11/29/2000 | CN1274719A Process for preparation of substituted pyridine compound |
| 11/29/2000 | CN1274718A Novel benzo-[3,4] cyclobutano [1,2-C] pyrroles compound, its prepn. and medicine composition containing the same |
| 11/29/2000 | CN1274711A New intermediate for preparation of anti-histamine piperidine derivatives |
| 11/29/2000 | CN1274603A Externally-used arthralgia treating medicine and its preparation |
| 11/29/2000 | CN1274601A Immunity-strengthening and infection-preventing medicine |
| 11/29/2000 | CN1274586A Burn and scald treating external-use ointment |
| 11/29/2000 | CN1274582A Oral cesporan with long effect |
| 11/29/2000 | CN1274581A Application of Alpha-adrenaline receptor blocking agent in preparing medicine for man's sexual dysfunction |
| 11/29/2000 | CN1274580A Stable delayed vitamin C preparation and its production process |
| 11/29/2000 | CN1274579A Method for producing particle with hepatoflavin |
| 11/29/2000 | CN1274578A Preparation of Azithromycin solution and semi-solid |
| 11/29/2000 | CN1058968C Novel pyrido [3,2-e] pyrazinones with anti-asthmatic action and process for their manufacture |
| 11/29/2000 | CN1058967C Novel pyridine compounds, processes for their preparation and pharmaceutical compositions thereof |
| 11/29/2000 | CN1058966C Producing process for crystal of z-oxyethyl -1-[2'-(1H-tetrazole-5-radical) diphenyl-4-(methyl) benzimidazole-7-hydroxy acid 1-(cyclohexyloxy) |
| 11/29/2000 | CN1058965C New thiophene compounds, process for their preparation and pharmaceutical compositions containing them |
| 11/29/2000 | CN1058964C Branched-amino-sbustituted thiazoles, process for their preparation and the pharmaceutical compositions which contain them |
| 11/29/2000 | CN1058962C N4-antipyrinyl-4-hydrxy-3-methoxy cinnamide and producing process thereof |
| 11/29/2000 | CN1058894C Compound cold-preventing nose drops and their preparation |
| 11/29/2000 | CN1058880C Compound antibacterial and antiviral veterinary medicine capable of raising immunity |
| 11/29/2000 | CN1058869C Chinese traditional medicine of hair lotion and preparing process |
| 11/29/2000 | CN1058866C Medicinal composition for treating tinea manus and pedis |
| 11/29/2000 | CN1058865C Cream for treating tinea cruris |
| 11/29/2000 | CA2310174A1 Pyrazolo(3,4-d)(1,2,3)triazines having anticonvulsant activity and processes for their preparation |
| 11/28/2000 | US6153774 Silver ion chromatography of high purity conjugated linoleic acid (CLA) |
| 11/28/2000 | US6153768 Benzopyran derivatives |
| 11/28/2000 | US6153754 Process for production of piperidine derivatives |
| 11/28/2000 | US6153751 Preparing the antiviral b-isomer of a 1,3-oxathiolane nucleoside by reacting in presence of stannic chloride |
| 11/28/2000 | US6153736 Modified ether glyceroglycolipids |
| 11/28/2000 | US6153731 Dehydrodidemnin B |
| 11/28/2000 | US6153654 Method of improving outcome of cardiopulmonary bypass surgery |
| 11/28/2000 | US6153653 Choline compositions and uses thereof |
| 11/28/2000 | US6153652 N-(aryl/heteroaryl/alkylacetyl) amino acid amides, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds |
| 11/28/2000 | US6153651 Ortho-substituted benzoylguanidines, process for their preparation, their use as a medicament or diagnostic, and medicament comprising them |
| 11/28/2000 | US6153650 Treatment of epilepsy, faintness attacks, hypokinesia, cranial disorders, neurodegenerative disorders, depression, anxiety, panic, pain, neuropathological disorders, inflammation, and gastrointestinal damage. |
| 11/28/2000 | US6153649 Use of carboxylic acids having a sulphur function for promoting skin exfoliation or stimulating epidermal regeneration |
| 11/28/2000 | US6153647 Method for augmenting the inotropic effects of β-adrenergic agonists using pyruvate therapy |
| 11/28/2000 | US6153646 Binuclear platinum complexes, method for preparing same and pharmaceutical compositions containing said complexes |
| 11/28/2000 | US6153644 Stabilized injectable pharmaceutical compositions containing taxoid anti-neoplastic agents |
| 11/28/2000 | US6153643 Anti-cancer-substance |
| 11/28/2000 | US6153642 Useful as antineoplastic and antiviral agents |
| 11/28/2000 | US6153640 For treating depression, panic attacks, obsessive-compulsive disorders, phobias, impulsive disorders, drug abuse or anxiety |
| 11/28/2000 | US6153639 Treatment of tumors by irradiating with light after administration of protoporphyrin derivative |
| 11/28/2000 | US6153638 Administering efaroxan or its salt in racemic form or in the form of an optically-active isomer for treating huntington's disease |
| 11/28/2000 | US6153635 Methods and kits for treating vulvovaginal candidiasis with miconazole nitrate |
| 11/28/2000 | US6153631 Treating condition in vertebrate animal characterized by a deficiency in, or need for, bone growth replacement and/or an undesirable level of bone resorption, by administering to benzothiazole derivative |
| 11/28/2000 | US6153630 Phenylpyridyl compounds for inhibiting phosphodiesterase IV and methods of using same |
| 11/28/2000 | US6153628 1,3,4-thiadiazoles and 1,3,4-Oxadiazoles as αv β3 antagonists |
| 11/28/2000 | US6153626 For treating pain, gastrointestinal disorders, spinal cord injury |
| 11/28/2000 | US6153625 For treatment of disorders in which involvement of serotoninergic system has been demonstrated, as in psychiartic disorders such as depression, anxiety, panic attack, schizophrenia, aggression, impulsive disorders |
| 11/28/2000 | US6153624 Pyrrolidine and piperidine derivatives and treatment of neurodegenerative disorders |
| 11/28/2000 | US6153623 Cisapride extended release |
| 11/28/2000 | US6153622 Estrogen agonists/antagonists |
| 11/28/2000 | US6153621 Combined antagonist compositions |
| 11/28/2000 | US6153620 Opiate receptor antagonist modulates movement disorder |
| 11/28/2000 | US6153615 Administering nitric oxide synthesis inhibiting amount of dihydrofolate reductase inhibitor, catecholamine replacing non-toxic amount of levodopa with or without carbidopa and serotonin replacing non-toxic amount of l-5-hydroxytryptophane |
| 11/28/2000 | US6153614 Piperazinyl pyrimidine dione compounds selective for adrenoceptors |
| 11/28/2000 | US6153611 As non-dopaminergic antiischemic compounds for treating brain disorders |
| 11/28/2000 | US6153610 For treating cancer tumors |
| 11/28/2000 | US6153609 Arylsulfonylamino hydroxamic acid derivatives |
| 11/28/2000 | US6153608 Isoquinoline derivatives and drugs |
| 11/28/2000 | US6153607 Non-preserved topical corticosteroid for treatment of dry eye, filamentary keratitis, and delayed tear clearance (or turnover) |
| 11/28/2000 | US6153606 Memory enhancement by the administration of Δ5-androstene-3β-ol-7,17-dione and 3β esters thereof |
| 11/28/2000 | US6153605 Useful in treatment or prevention of vitamin d dependent disorders, particularly psoriasis, basal cell carcinomas, disorders of keratinization and keratosis, leukemia, osteoporosis, hyperparathyroidism accompanying renal failure |
| 11/28/2000 | US6153604 Treating disease of nervous system in which pathophysiology of disorder involves excessive excitation of nerve cells by agonists of nmda receptors, comprising administering to guanidine derivative |
| 11/28/2000 | US6153603 Method of treating angiogenesis in tumor tissue |
| 11/28/2000 | US6153601 Polyholoside compositions for stimulating the immune system |
| 11/28/2000 | US6153598 Acts as synthetic vector for achieving efficient transfection of associated nucleic acid into a cell; gene therapy |
| 11/28/2000 | US6153597 For gene therapy such as in vitro, ex vivo and/or in vivo transfer of genetic material |
| 11/28/2000 | US6153595 Composition and method for treatment of CMV infections |
| 11/28/2000 | US6153594 5'-O-acylated antiviral nucleosides |
| 11/28/2000 | US6153589 2,3-epoxy alcohols, acids and derivatives as anti retroviral chemotherapeutic agents |
| 11/28/2000 | US6153433 Suppressing microorganismal propagation; insertion of nucleotide sequences coding viricidal polypeptide into cells infected with hepatitis viral agent, monitor for propagation |
| 11/28/2000 | US6153430 Used as indicator of the presence of ovarian cancer tumor cells |
| 11/28/2000 | US6153396 Drug screening by adding compound to mixture of chaperone and pilus subunit and determining the change in binding; bactericides for urinary tract infections |
| 11/28/2000 | US6153242 Method for preparing snack food |
| 11/28/2000 | US6153225 Injectable formulations of nanoparticulate naproxen |
| 11/28/2000 | US6153220 Taste-masked formulations |
| 11/28/2000 | US6153217 Nanocochleate formulations, process of preparation and method of delivery of pharmaceutical agents |
| 11/28/2000 | US6153216 Transdermal estradiol/progestogen agent patch and its production |
| 11/28/2000 | US6153207 Anti-cellulite pantyhose |
| 11/28/2000 | US6153200 Administering an isolated and purified bacterial dnajp1 peptide having the amino acid sequence |
| 11/28/2000 | US6153193 Compositions for targeting biological agents |
| 11/28/2000 | US6153186 Red blood cells loaded with S-nitrosothiol and uses therefor |
| 11/28/2000 | US6153180 Agent and method for permanently shaping the hair, based on n-branched-chain alkyl-substituted mercapto acetamides and process for their preparation |
| 11/28/2000 | US6153171 Methods for identifying compounds effective for treating neurodegenerative disorders and for monitoring the therapeutic intervention therefor |
| 11/28/2000 | US6153129 Production scale method of forming microparticles |
| 11/28/2000 | US6152926 Spine distraction implant and method |
| 11/28/2000 | CA2309520A1 Compositions for stabilizing oxygen-labile species |
| 11/28/2000 | CA2309505A1 New 4-arylpiperidine derivatives for the treatment of pruritus |
| 11/28/2000 | CA2309475A1 New 4-arylpiperidine derivatives for the treatment of pruritus |
| 11/28/2000 | CA2309434A1 New 4-arylpiperidine derivatives for the treatment of pruritus |
| 11/28/2000 | CA2309375A1 Polycaprolactone-b-poly(ethylene oxide) copolymer micelles as a delivery vehicle for steroid |
| 11/28/2000 | CA2307357A1 Wbpp and method for assay of wbpp |
| 11/28/2000 | CA2300452C Orally administrable solid ribavirin dosage forms and process for making them |
| 11/28/2000 | CA2267136C Lactose-free, non-hygroscopic and anhydrous pharmaceutical compositions of descarboethoxyloratadine |
| 11/28/2000 | CA2254506C Piperidine derivatives and process for their production |
| 11/28/2000 | CA2200795C Methods of inducing analgesia or anesthesia and treating or preventing ischemic injury of tissues in general |
| 11/28/2000 | CA2192820C Pyrazolo and pyrrolopyridines |
| 11/28/2000 | CA2182970C Lyophilized stem cell factor formulations |
| 11/28/2000 | CA2182575C Oil-in-water emulsions |